Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
PL01 - Opening Plenary: Access and Disparities (Japanese, Mandarin, Spanish Translation Available)
- 07:00 - 08:00
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:Lucia Zatarain Barron, Tetsuya Mitsudomi
-
+
PL01.01 - Introduction and IASLC Award Presentations
07:00 - 07:30
- Abstract
No abstract available for this presentation
-
+
PL01.02 - Disparities in Lung Cancer Care Across the Population
07:30 - 07:40 | Presenter: Raymond Uyiosa Osarogiagbon
- Abstract
Loading... -
+
PL01.03 - Disparities in Lung Cancer Care: The Global Burden
07:40 - 07:50 | Presenter: Alex Adjei
- Abstract
No abstract available for this presentation
-
+
PL01.04 - Live Discussion with Speakers
07:50 - 08:00
- Abstract
No abstract available for this presentation
-
+
P04 - Early Stage/Localized Disease/Ablative Therapies - Nodule Evaluation
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Early Stage/Localized Disease/Ablative Therapies
-
+
P04.01 - Presence of Ground Glass Opacity Component is True Determinant of Prognosis in Clinical Stage I Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Akira Hamada
- Abstract
Loading...
-
+
P68 - Tumor Biology and Systems Biology: Basic and Translational Science - Advances in Lung Cancer
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Tumor Biology and Systems Biology: Basic and Translational Science
-
+
P68.12 - Inter-Tumor Heterogeneity of CD44 Expression in Non-Small Cell Lung Cancers / EGFR Mutated Lung Adenocarcinomas
00:00 - 00:00 | Presenter: Kenichi Suda
- Abstract
Loading...
-
+
PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)
- 06:30 - 08:00
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:David Harpole, Tetsuya Mitsudomi
-
+
PL02.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study
06:30 - 06:40 | Presenter: Melissa L Johnson
- Abstract
Loading... -
+
PL02.02 - Discussant
06:40 - 06:47 | Presenter: Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
PL02.03 - Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial
06:47 - 06:57 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
PL02.04 - Discussant
06:57 - 07:04 | Presenter: Charles M Rudin
- Abstract
No abstract available for this presentation
-
+
PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
07:04 - 07:14 | Presenter: Nasser Altorki
- Abstract
Loading... -
+
PL02.06 - Discussant
07:14 - 07:21 | Presenter: Ichiro Yoshino
- Abstract
No abstract available for this presentation
-
+
PL02.07 - Global Variability in Lung Cancer Deaths Attributable to Air Pollution
07:21 - 07:31 | Presenter: Christine Dorothy Berg
- Abstract
Loading... -
+
PL02.08 - Discussant
07:31 - 07:38 | Presenter: Joachim G.J.V. Aerts
- Abstract
No abstract available for this presentation
-
+
PL02.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials
07:38 - 07:48 | Presenter: Matthew Smeltzer
- Abstract
Loading... -
+
PL02.10 - Discussant
07:48 - 07:55 | Presenter: Marina Chiara Garassino
- Abstract
No abstract available for this presentation
-
+
PL02.11 - Live Discussion with Speakers
07:55 - 08:00
- Abstract
No abstract available for this presentation
-
+
PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)
- 14:30 - 16:00
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:David Harpole, Tetsuya Mitsudomi
-
+
PL02A.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study
14:30 - 14:40 | Presenter: Melissa L Johnson
- Abstract
Loading... -
+
PL02A.02 - Discussant
14:40 - 14:47 | Presenter: Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
PL02A.03 - Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial
14:47 - 14:57 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
PL02A.04 - Discussant
14:57 - 15:04 | Presenter: Charles M Rudin
- Abstract
No abstract available for this presentation
-
+
PL02A.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
15:04 - 15:14 | Presenter: Nasser Altorki
- Abstract
Loading... -
+
PL02A.06 - Discussant
15:14 - 15:21 | Presenter: Ichiro Yoshino
- Abstract
No abstract available for this presentation
-
+
PL02A.07 - Global Variability in Lung Cancer Deaths Attributable to Air Pollution
15:21 - 15:31 | Presenter: Christine Dorothy Berg
- Abstract
Loading... -
+
PL02A.08 - Discussant
15:31 - 15:38 | Presenter: Joachim G.J.V. Aerts
- Abstract
No abstract available for this presentation
-
+
PL02A.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials
15:38 - 15:48 | Presenter: Matthew Smeltzer
- Abstract
Loading... -
+
PL02A.10 - Discussant
15:48 - 15:55 | Presenter: Marina Chiara Garassino
- Abstract
No abstract available for this presentation
-
+
PL02A.11 - Live Discussion with Speakers
15:55 - 16:00
- Abstract
No abstract available for this presentation
-
+
GA01 - IASLC General Assembly
- 15:00 - 16:00
- 9/12/2021
- Location: Program Auditorium
- Type: Highlights
- Track: N.A.
-
+
GA01.01 - Welcome
15:00 - 15:00 | Presenter: Tetsuya Mitsudomi
- Abstract
No abstract available for this presentation
-
+
GA01.02 - Recognition of Outgoing & Incoming IASLC Board of Directors
15:00 - 15:00 | Presenter: Tetsuya Mitsudomi, Heather Wakelee
- Abstract
No abstract available for this presentation
-
+
GA01.06 - IASLC President Parting Comments
15:00 - 15:00 | Presenter: Tetsuya Mitsudomi
- Abstract
No abstract available for this presentation
-
+
BEDG07 - Lung Ambition Alliance with AstraZeneca - Accelerating the Early Diagnosis of Lung Cancer at Local Level
- 21:15 - 22:15
- 9/13/2021
- Location: Brain Exchange Lounge
- Not for CME Credit
- Type: Brain Exchange Discussion Groups
- Track: N.A.
- Moderators:Tetsuya Mitsudomi, Pan Chyr Yang, David Lam, Mozziyar Etemadi, Raymond Uyiosa Osarogiagbon
-
+
BEDG07.01 - Welcome, Introductions and Session Overview
21:15 - 21:15
- Abstract
No abstract available for this presentation
-
+
BEDG07.02 - Time for Screening of Lung Cancer Is Now
21:15 - 21:15
- Abstract
No abstract available for this presentation
-
+
BEDG07.03 - IPN Detection as a Complementary Strategy
21:15 - 21:15
- Abstract
No abstract available for this presentation
-
+
BEDG07.04 - Potential of AI in Early Lung Cancer Detection
21:15 - 21:15
- Abstract
No abstract available for this presentation
-
+
BEDG07.05 - Case Studies/Best Practices
21:15 - 21:15
- Abstract
No abstract available for this presentation
-
+
BEDG07.06 - Discussion/Q&A
21:15 - 21:15
- Abstract
No abstract available for this presentation